Hologic Reports 3 Percent Drop in Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) —Hologic reported after the close of the market on Monday that fiscal first-quarter revenues declined 3 percent year over year, although its molecular diagnostic product sales helped mitigate this decline.

For the three months ended Dec. 28, 2013, Hologic's revenues totaled $612.4 million compared to $631.4 million a year ago, but besting the consensus Wall Street estimate of $609.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature News explores the president's "science legacy."

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.